{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:09:49Z","timestamp":1711584589892},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,8]]},"DOI":"10.1212\/wnl.47.2.544","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:22:30Z","timestamp":1336915350000},"page":"544-546","update-policy":"http:\/\/dx.doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes"],"prefix":"10.1212","volume":"47","author":[{"given":"Daniel R.","family":"Scoles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Baser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan-M.","family":"Pulst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"8","volume":"29","year":"1992","unstructured":"Evans DGR, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 1992;29:841-846.","journal-title":"J Med Genet"},{"key":"e_1_3_1_3_2","first-page":"8","volume":"38","year":"1996","unstructured":"Mautner VF, Lindenau M, Baser M, et al. The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 1996;38:880-886.","journal-title":"Neurosurgery"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870120102"},{"key":"e_1_3_1_5_2","first-page":"8","volume":"3","year":"1994","unstructured":"Bourn D, Carter SA, Mason S, Evans DGR, Strachan T. Germline mutations in the neurofibromatosis type 2 tumor suppressor gene. Hum Mol Genet 1994;3:813-816.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_6_2","first-page":"8","volume":"3","year":"1994","unstructured":"Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst S-M. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 1994;3:885-891.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_7_2","first-page":"4","volume":"3","year":"1994","unstructured":"Jacoby LB, MacCollin M, Louis DM, et al. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 1994;3:413-419.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_8_2","first-page":"2","volume":"270","year":"1993","unstructured":"MacCollin M, Mohney T, Trofatter J, Wertelecki W, Ramesh V, Gusella J. DNA diagnosis of neurofibromatosis 2. JAMA 1993;270:2316-2330.","journal-title":"JAMA"},{"key":"e_1_3_1_9_2","first-page":"4","volume":"32","year":"1995","unstructured":"Evans DGR, Bourn D, Wallace A, Ramaden RT, Mitchell JD, Strachan T. Diagnostic issues in a family with late onset type 2 neurofibromatosis. J Med Genet 1995;32:470-474.","journal-title":"J Med Genet"},{"key":"e_1_3_1_10_2","first-page":"2","volume":"97","year":"1996","unstructured":"Kluwe L, Mautner V-F. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2. Hum Genet 1996;97:224-227.","journal-title":"Hum Genet"},{"key":"e_1_3_1_11_2","first-page":"3","volume":"3","year":"1994","unstructured":"Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Somatic NF2 gene mutations in familial and nonfamilial vestibular schwannoma. Hum Mol Genet 1994;3:347-350.","journal-title":"Hum Mol Genet"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0194-1"},{"key":"e_1_3_1_13_2","first-page":"6","volume":"55","year":"1994","unstructured":"Bourn D, Carter SA, Evans DGR, Goodship J, Coakham H, Strachan T. A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals. Am J Hum Genet 1994;55:69-73.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_1_14_2","first-page":"4","volume":"4","year":"1995","unstructured":"Kluwe L, Pulst SM, Koppen J, Mautner V-F. A 163-bp deletion at the C-terminus of the schwannomin gene associated with variable phenotypes of neurofibromatosis type 2. Hum Genet 1995;4:443-446.","journal-title":"Hum Genet"},{"key":"e_1_3_1_15_2","unstructured":"Baser ME Ragge NK Riccardi VM Ganz B Janus T Pulst S-M. Phenotypic variability in monozygotic twins with neurofibromatosis 2. Am J Med Genet (In press)."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.47.2.544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:23:56Z","timestamp":1711535036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.2.544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,8]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1996,8]]}},"alternative-id":["10.1212\/WNL.47.2.544"],"URL":"https:\/\/doi.org\/10.1212\/wnl.47.2.544","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,8]]}}}